Starting CRC screening at 45 may add years of life — 6 GI industry notes

 

Here are six updates from gastroenterology companies and practices from the past week:

Tucson-based University of Arizona researchers have identified a biomarker that appears in patients before they develop stomach cancer.

In Wisconsin, Epic and Exact Sciences are decreasing COVID-19 test turnaround time by inputting results directly into Epic's MyChart program.

CMS issued a proposal that declined to cover the first FDA-approved blood-based colorectal cancer screening test, but created a guideline for still-in-development tests to earn approval.

Gastroenterology-focused Dr. Reddy's Laboratories was the victim of a cyberattack.

Using a noninvasive test to screen for colorectal cancer when a patient turned 45 years old added life years and decreased CRC incidence compared to starting screening when a patient turned 50 years old.

COVID-19 patients with gastrointestinal symptoms had higher admission rates to hospitals and intensive care units and higher intubation rates than those without GI symptoms, according to a poster presented at ACG 2020, Oct. 23-28.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like